Dyanavel® XR Extended-Release Oral Suspension in the Treatment of Children With ADHD: A Laboratory School Study

Clinical trial NCT03088267 · COMPLETED

Trial details

NCT number

NCT03088267

Sponsor

Tris Pharma, Inc.

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2017-02-11

Primary completion

2017-02-25

Enrollment

18

View on ClinicalTrials.gov